In order to assess the possible role of PDE4D loss on neuronal integrity and its potential role in increasing AD pathology risk, we examined phosphorylation of tau at S214, a phosphorylation site that is evident in early AD pathology (Augustinack et al., 2002). The gene discussed is MAPT; the disease is Alzheimer disease.